Top compounds associated with response to CCDC160


Feature Type Standardized
Nominal ANOVA
mRNA brivanib CTRPv2 pan-cancer AAC 0.067 0.05
mRNA lapatinib CTRPv2 pan-cancer AAC 0.068 0.06
mRNA AMG-706 GDSC1000 pan-cancer AAC 0.073 0.06
mRNA neratinib CTRPv2 pan-cancer AAC 0.066 0.06
mRNA AA-COCF3 CTRPv2 pan-cancer AAC 0.066 0.06
mRNA manumycin A CTRPv2 pan-cancer AAC 0.06 0.06
mRNA AZD4547 CTRPv2 pan-cancer AAC 0.07 0.06
mRNA AZD6244 UHNBreast pan-cancer AAC -0.54 0.06
mRNA fulvestrant CTRPv2 pan-cancer AAC 0.14 0.06
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC 0.066 0.06
Download CSV